Directly comparing calcium responses across age cohorts showed that responses to 3-hexanone and isopropanol each significantly declined with age in 5 out of 6 glomeruli (3-hexanone, all except PG b ; isopropanol, all except G1)
Results, paragraph 9; Figure 4; Figure S4B
What the paper reports
- 3-hexanone, PGa: Welch's t test, p = 0.014
- 3-hexanone, G1: Welch's t test, p = 0.026
- 3-hexanone, G2: Welch's t test, p = 0.0012
- 3-hexanone, G3: Welch's t test, p = 1.7 × 10⁻⁴
- 3-hexanone, G4: Welch's t test, p = 0.0015
- isopropanol, PGb: Welch's t test, p = 0.044
- isopropanol, PGa: Welch's t test, p = 0.011
- isopropanol, G2: Welch's t test, p = 0.0024
- isopropanol, G3: Welch's t test, p = 0.008
- isopropanol, G4: Welch's t test, p = 0.0084
At the held-out placement (reading a, radius 8) 9 of the 10 declines are significant: 3-hexanone in PGa, G2, G3 and G4 (p = 0.016, 0.0498, 0.048, 0.020) but not G1 (p = 0.12), isopropanol in all five (PGb 0.008, PGa 0.0098, G2 0.019, G3 0.021, G4 0.025), so at least four of five decline for each odorant, the partial level. 3-hexanone in PGb, not significant in the paper, declines here (29.0 against 12.8, p = 0.022); isopropanol in G1 does not (p = 0.20), as in the paper. The partial level rests on two p-values just under 0.05 and is not met under any of the eight other variants (5 to 8 of 10, one odorant 3 or fewer of 5), including the placement from all trials (7 of 10, isopropanol 3 of 5; not reproduced in round 1). With all trials in place of Data S2's trials, G2 with 3-hexanone gives p = 0.059. Data S2's own values give all 10, with PGb 3-hexanone p = 0.23. The located ROIs bias this claim toward passing. On held-out trials only 9 of 52 old-ant glomerulus traces follow Data S2's, so old-ant values are read partly where the glomerulus is not, which pulls old means down; claims that need old ants to be lower (this one) are pushed toward passing, those that need them higher (fig3d, the late window of figs4d) toward failing. The PGb decline with 3-hexanone is the visible case (old mean 12.8 here against Data S2's 25.1 for the same ants). Changed from not reproduced with the held-out placement.
How the test differed from the paper’s method
- Glomerulus positions are not in the dandiset; each is placed where the dandiset's per-trial responses best correlate with Data S2's (data-s2-glomerulus-link), so the test uses Data S2 (data with_inputs).
- Assumed the held-out placement as the main measure: each odor's AUCs are read where the glomerulus was placed from Data S2's trials of the other odors (leave one odor out), so that the tested values did not choose the place (verifier, round 1, problem 2). The placement from all trials (round 1's main measure), placements above chance only, and for the alarm pheromones the placement from the general odorants alone are shown as variants.
- Assumed a disk ROI of 8 pixels radius (2.3 um) on the three-plane projection; the paper gives no ROI size. Radii 5 and 12 are shown.
- Assumed fold-change reading (a), the ROI mean of the projected signal turned into fold change, the usual ImageJ order for "a max Z-projection was generated ... and the fluorescence fold change was calculated" (STAR Methods, Image processing); reading (b) is shown, leaving out pixels whose baseline F0 is at or below the ant's background level (the median of the raw maximum projection outside the AL), an assumption, since a pixel at background level divides by noise.
- Per ant, the mean over the trials Data S2 holds for that glomerulus (the paper's own trial selection); all trials are shown as a variant.
- The 40-frame traces are aligned with one set of shifts per trial, measured on the middle plane, not per plane.